$267 Million is the total value of Argyle Capital Management Inc.'s 127 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DEO | New | Diageo PLCspon adr new | $219,000 | – | 1,500 | +100.0% | 0.08% | – |
| MCO | New | Moodys Corp | $207,000 | – | 1,400 | +100.0% | 0.08% | – |
| AET | New | Aetna Inc New | $204,000 | – | 1,131 | +100.0% | 0.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-01-25
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft Corp | 42 | Q3 2023 | 5.3% |
| Merck & Co Inc | 42 | Q3 2023 | 3.2% |
| Pfizer Inc | 42 | Q3 2023 | 2.8% |
| Amgen Inc | 42 | Q3 2023 | 2.9% |
| Intel Corp | 42 | Q3 2023 | 3.1% |
| Bristol Myers Squibb Co | 42 | Q3 2023 | 2.9% |
| Paychex Inc | 42 | Q3 2023 | 2.3% |
| Lilly Eli Co | 42 | Q3 2023 | 4.4% |
| Verizon Communications | 42 | Q3 2023 | 2.6% |
| Johnson & Johnson | 42 | Q3 2023 | 2.2% |
View Argyle Capital Management Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-29 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-10-26 |
| 13F-HR | 2023-07-27 |
| 13F-HR | 2023-04-27 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-20 |
| 13F-HR | 2022-04-27 |
| 13F-HR | 2022-01-25 |
View Argyle Capital Management Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.